Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Standard antipsychotic therapy
DRUG
2 trials
Sponsors
Hoffmann-La Roche
Conditions
Schizophrenia
Phase 1
A Study of the Effect of RO4917838 on Biomarker Measures of Cognitive Dysfunction in Participants With Schizophrenia and Schizoaffective Disorder
Completed
NCT01116830
Hoffmann-La Roche
Schizophrenia
Start: 2010-11-30
End: 2014-02-28
Updated: 2016-11-02
Phase 2
A Study of RO4917838 in Combination With Antipsychotic Treatment in Patients With Schizophrenia.
Completed
NCT00616798
Hoffmann-La Roche
Schizophrenia
Start: 2008-03-31
End: 2010-02-28
Updated: 2014-06-24
Related Papers
Improvement in mismatch negativity generation during d-serine treatment in schizophrenia: Correlation with symptoms.
2017-03-18
98 citations
Effect of Bitopertin, a Glycine Reuptake Inhibitor, on Negative Symptoms of Schizophrenia
JAMA Psychiatry
2014-04-02
227 citations